Cargando…

Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients

Presently, there is inconclusive evidence regarding the most effective treatment for idiopathic nonhistaminergic acquired angioedema (InH-AAE). Omalizumab may, however, prove to be a promising option. This case report describes two patients who presented with recurrent angioedema attacks, which was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunetta, Enrico, Shiffer, Dana, Folci, Marco, Achenza, Maria I. S., Puggioni, Francesca, Heffler, Enrico, Furlan, Raffaello, Canonica, Giorgio W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081528/ https://www.ncbi.nlm.nih.gov/pubmed/30140474 http://dx.doi.org/10.1155/2018/8067610

Ejemplares similares

Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria
por: Folci, Marco, et al.
Publicado: (2018)

Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019
por: Azmy, Veronica, et al.
Publicado: (2020)

Autonomic Abnormalities in Patients With Primary Sjogren’s Syndrome – Preliminary Results
por: Brunetta, Enrico, et al.
Publicado: (2019)

87 Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant
por: Lleonart, Ramon, et al.
Publicado: (2012)

ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
por: Folci, Marco, et al.
Publicado: (2019)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema
por: Kutlu, Ali, et al.
Publicado: (2016)

Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis
por: Heffler, Enrico, et al.
Publicado: (2018)

Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019)

A Natural Language Processing–Based Virtual Patient Simulator and Intelligent Tutoring System for the Clinical Diagnostic Process: Simulator Development and Case Study
por: Furlan, Raffaello, et al.
Publicado: (2021)

Learning Analytics Applied to Clinical Diagnostic Reasoning Using a Natural Language Processing–Based Virtual Patient Simulator: Case Study
por: Furlan, Raffaello, et al.
Publicado: (2022)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
por: Solidoro, Paolo, et al.
Publicado: (2019)

Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema
por: Maurer, M., et al.
Publicado: (2017)

A critical appraisal on AIT in childhood asthma
por: Ferrando, Matteo, et al.
Publicado: (2018)

Omalizumab in recurring larynx angioedema: a case report
por: Ozturk, Ayse Bilge, et al.
Publicado: (2014)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Serum ANCA and Overall Mortality: A 10-Year Retrospective Cohort Study on 1,024 Italian Subjects
por: Brunetta, Enrico, et al.
Publicado: (2021)

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs
por: Varricchi, Gilda, et al.
Publicado: (2016)

An academic allergy unit during COVID-19 pandemic in Italy
por: Malipiero, Giacomo, et al.
Publicado: (2020)

Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
por: Popov, Todor A., et al.
Publicado: (2019)

Artificial Intelligence Algorithms and Natural Language Processing for the Recognition of Syncope Patients on Emergency Department Medical Records
por: Dipaola, Franca, et al.
Publicado: (2019)

Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome
por: Ramponi, Giacomo, et al.
Publicado: (2020)

Autoinflammatory manifestations in adult patients
por: Rodolfi, Stefano, et al.
Publicado: (2022)

Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line
por: Costanzo, Giovanni, et al.
Publicado: (2023)

Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas
por: Morandini, Pierandrea, et al.
Publicado: (2022)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
por: Nappi, Emanuele, et al.
Publicado: (2022)

Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era
por: Nappi, Emanuele, et al.
Publicado: (2023)

Cardiovascular autonomic disorders and work ability: A focus on post-acute Covid19 syndrome
por: Barbic, Franca, et al.
Publicado: (2022)

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
por: Malipiero, Giacomo, et al.
Publicado: (2020)

Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions
por: Messina, Maria Rita, et al.
Publicado: (2023)

Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps
por: Baiardini, Ilaria, et al.
Publicado: (2022)

Personalized Approach to Severe Asthma
por: Heffler, Enrico, et al.
Publicado: (2018)

Immunostimulants in respiratory diseases: focus on Pidotimod
por: Puggioni, Francesca, et al.
Publicado: (2019)

Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()
por: Paoletti, Giovanni, et al.
Publicado: (2021)

Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
por: Nappi, Emanuele, et al.
Publicado: (2023)

Idiopathic Angioedema: Current Challenges
por: Belbézier, Aude, et al.
Publicado: (2020)

Machine Learning and Syncope Management in the ED: The Future Is Coming
por: Dipaola, Franca, et al.
Publicado: (2021)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
por: Varricchi, Gilda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t4rkmqai343h2t2o0l9v97vd3p